Ionis Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT FACTOR B EXPRESSION

Last updated:

Abstract:

The present embodiments provide methods, compounds, and compositions for treating, preventing, or ameliorating a disease associated with dysregulation of the complement alternative pathway by administering a Complement Factor B (CFB) specific inhibitor to a subject.

Status:
Application
Type:

Utility

Filling date:

18 Mar 2019

Issue date:

13 Feb 2020